Atomics AI Overview
- Industry
- Biotechnology Research
- Employees
- 6
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Atomics AI
Atomics is revolutionizing drug discovery by combining quantum physics-based molecular modeling with AI machine learning algorithms, enabling the ultra-fast and accurate prediction of protein-drug binding probabilities. Founded by Dr. Kyuho Lee, Atomics leverages advanced simulations to dramatically reduce the time and cost of developing new, highly effective drugs with fewer side effects.